Last reviewed · How we verify

NCT05715008

Kefir Consumption on Various Parameters in Adults Subjects

Status unknown NA Last updated 6 February 2023
What this trial tests

NA trial testing Kefir in Oxidative Stress in 16 participants. Status unknown.

Timeline
30 January 2023
Primary endpoint
30 March 2023
20 June 2023

Quick facts

Lead sponsorUniversity of Thessaly
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposetreatment
Enrollment16
Start date30 January 2023
Primary completion30 March 2023
Estimated completion20 June 2023

Drugs / interventions tested

Conditions studied

Sponsor

University of Thessaly

Who can join

Adults 18 to 65, any sex, with Oxidative Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine the effect of kefir consumption on anthropometric, physiological and redox status parameters in adult subjects, and compare it with the intake of placebo drink (milk).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Kefir

Trials testing the same drug.

Other recruiting trials for Oxidative Stress

Currently open trials in the same condition.

Other University of Thessaly trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05715008.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing